George W Lloyd

George W Lloyd

General Counsel · Royalty Pharma plc

Rank #2,021 SEC EDGAR (United States) ↗ Files from United States

Details

Officer of the companyPharmaceuticals & BiotechnologyRPRXSEC CIK 0001814899

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$49.9M
1-day change
▲ 0.13%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$27.3M – $49.9M2026-09-04

Insider activity May 8, 2025 – Dec 18, 2025

George W Lloyd is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 14 transactions between May 8, 2025 and Dec 18, 2025. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$13.81M
11 sales on file priced rows only
All reported transactions
14
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

George W Lloyd sold 79,346 Royalty Pharma plc (RPRX) shares for $3,060,375 on Dec 17, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

George W Lloyd sold 79,346 Royalty Pharma plc (RPRX) shares for $3,060,375 on Dec 17, 2025
Date Insider Transaction Shares Price Value Filing
Dec 17, 2025 George W Lloyd S Open-market sale 79,346 held after: 30,654 $38.57 $3,060,375 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

George W Lloyd sold 110,000 Royalty Pharma plc (RPRX) shares for $4,374,700 on Dec 3, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

George W Lloyd sold 110,000 Royalty Pharma plc (RPRX) shares for $4,374,700 on Dec 3, 2025
Date Insider Transaction Shares Price Value Filing
Dec 3, 2025 George W Lloyd S Open-market sale 110,000 held after: 110,000 $39.77 $4,374,700 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 14 most recent rows are grouped into 7 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Royalty Pharma plc RPRX S Open-market sale 30,654 shares $1.18M at $38.50 SEC filing ↗
  2. Royalty Pharma plc RPRX S Open-market sale 79,346 shares $3.06M at $38.57 SEC filing ↗
  3. Royalty Pharma plc RPRX S Open-market sale 110,000 shares $4.37M at $39.77 SEC filing ↗
  4. Royalty Pharma plc RPRX S Open-market sale × 8 135,426 shares $5.19M
    The 8 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    2,770 $38.29 $106.1K SEC filing ↗
    2,470 $39.01 $96.4K SEC filing ↗
    25,530 $38.28 $977.3K SEC filing ↗
    47,401 $38.28 $1.81M SEC filing ↗
    4,628 $39.01 $180.5K SEC filing ↗
    47,798 $38.28 $1.83M SEC filing ↗
    230 $39.03 $9.0K SEC filing ↗
    4,599 $39.01 $179.4K SEC filing ↗
  5. Royalty Pharma plc RPRX A Grant or awardnot a buy/sell decisionreported at zero 6,168 shares $0 at $0.00 SEC filing ↗
  6. Royalty Pharma plc RPRX A Grant or awardnot a buy/sell decisionreported at zero 3,696 shares $0 at $0.00 SEC filing ↗
  7. Royalty Pharma plc RPRX A Grant or awardnot a buy/sell decisionreported at zero 48,646 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Royalty Pharma plc RPRX Class A Ordinary Shares (indirect) 779,915 $63.96 $49.9M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where George W Lloyd reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: Royalty Pharma plc (company-published photograph). Original file page on royaltypharma.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.